Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ApoDiag: A Prospective, Monocentric Clinical Study for the Validation of in Vitro Diagnostic Tests Developed by Firalis

NCT06432192 is registered in ClinicalTrials.gov with Firalis SA as lead sponsor.

NCT NCT06432192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06432192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ApoDiag: A Prospective, Monocentric Clinical Study for the Validation of in Vitro Diagnostic Tests Developed by Firalis
Lead sponsor
Firalis SA
Phase
Observational
Overall status
Completed
Start date
January 2, 2024
Completion date
March 25, 2025
Enrollment
1,474 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

genetic health risks